Last 3,395 KRW
Change Today -160.00 / -4.50%
Volume 930.8K
001360 On Other Exchanges
Symbol
Exchange
Korea SE
As of 2:17 AM 09/17/14 All times are local (Market data is delayed by at least 15 minutes).

samsung pharmaceutical co lt (001360) Snapshot

Open
3,540
Previous Close
3,555
Day High
3,540
Day Low
3,355
52 Week High
05/23/14 - 5,040
52 Week Low
12/20/13 - 1,710
Market Cap
74.3B
Average Volume 10 Days
1.1M
EPS TTM
-1,608.00
Shares Outstanding
21.9M
EX-Date
01/4/00
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SAMSUNG PHARMACEUTICAL CO LT (001360)

Related News

No related news articles were found.

samsung pharmaceutical co lt (001360) Related Businessweek News

No Related Businessweek News Found

samsung pharmaceutical co lt (001360) Details

Samsung Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical goods. The company offers over the counter and prescription drugs, including gastrointestinal drugs, drinks, hepatic protectors, detoxicants, cough and cold remedies, eye preparation drugs, antipyretics, analgesics, antiinflammatory drugs, topical drugs, multi-vitamins, cardiovascular drugs, antihistamines, antacid, drugs for obesity, drugs for periodontal diseases, antidiarrheals, antianemic agents, muscle relaxants, cholesterol reduction, cough suppressants, expectorants, antibiotics, antihyperlipidemia preparation, parenteral nutritions, antispasmodic, vasodilators, prokinetic agents, antihypertensive drugs, antifungal and antiarrhythmic agents, and others. It also provides insect killer products, such as killer aerosol, killer mats, killer liquids, and mosquito coils; healthcare products, including bath powders, cosmetic foods, and body perfumes; and energy drinks. The company was formerly known as Samsung Pharmaceutical Industry Corporation Limited and changed its name to Samsung Pharmaceutical Co., Ltd. in August 2014. Samsung Pharmaceutical Co., Ltd. was founded in 1929 and is based in Seoul, South Korea.

Founded in 1929

samsung pharmaceutical co lt (001360) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

samsung pharmaceutical co lt (001360) Key Developments

Samsung Pharmaceutical Industry Corporation Limited., Special/Extraordinary Shareholders Meeting, Jul 07, 2014

Samsung Pharmaceutical Industry Corporation Limited., Special/Extraordinary Shareholders Meeting, Jul 07, 2014., at 10:00 Korea Standard Time. Agenda: To consider articles of incorporation to change and add business purposes and to consider appointment of directors.

Samsung Pharmaceutical Plans to Amend Articles of Incorporation

Samsung Pharmaceutical Industry Corporation Limited., at its EGM to be held on July 07, 2014, plans to amend articles of incorporation to change and add business purposes.

Samsung Pharmaceutical Industry Corporation Limited., Annual General Meeting, Mar 22, 2013

Samsung Pharmaceutical Industry Corporation Limited., Annual General Meeting, Mar 22, 2013., at 10:00 Korea Standard Time. Location: junggokdong 614-4 Samsung constraints. Agenda: To consider the Article 59 group (01/01/2012 - 31/12/2012) approval of financial statements; to consider the appointment of Directors and House director; to consider the appointment of the Auditor; to consider the approval of remuneration of Director of the Audit Committee; and to consider the approval of remuneration limit.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
001360:KS 3,395.00 KRW -160.00

001360 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 001360.
View Industry Companies
 

Industry Analysis

001360

Industry Average

Valuation 001360 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.0x
Price/Book 2.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SAMSUNG PHARMACEUTICAL CO LT, please visit www.sspharm.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.